# US 2010/0074968 A1 · Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s)

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0074968 A1
- Document ID: US20100074968A1
- Status: Published application
- Kind: A1
- Application number: 12/626,980
- Filed: 2009-11-30
- Published: 2010-03-25
- Earliest claimed: 2003-10-17
- Assignees: Helsingfors Institution FöR Biommunterapi AB.
- Inventors: Thomas TALLBERG
- Web page: https://patentgrep.com/patent/US20100074968A1

## CPC

- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61K 33/24: Heavy metals; Compounds thereof
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- A61P 35/00: Antineoplastic agents
- A61P 35/04: specific for metastasis
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to the treatment and prophylaxis of cancer. In particular, the invention relates to a pharmaceutical agent comprising strontium, amino acid(s) and mineral element(s), and its use in the preparation of an agent useful for the treatment and prophylaxis of cancer. The invention also relates to a method for treatment and prophylaxis of cancer.

## Claims

### Claim at position 1

-11. (canceled)

### Claim 12

A method for the treatment or prophylaxis of cancer which comprises administering to a subject in need thereof a pharmaceutical agent which consists essentially of strontium, one or more amino acids selected from the group consisting of arginine, serine, asparagine, glycine, glutamine, lysine, one or more mineral elements selected from the group consisting of chromium, tin, vanadium and wolfram and one or more vitamins.

### Claim 13 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that strontium is present in in the pharmaceutical agent in the form of strontium ions.

### Claim 14 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that strontium is present in the pharmaceutical agent in the form of strontium chloride or strontium oxide.

### Claim 15 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent comprises 0.1-3 mg strontium, at least one L-amino acid selected from the group consisting of arginine, serine, asparagine, glycine, glutamine, lysine, in an amount of 2-5 g of each of the chosen amino acids, at least one mineral element selected from the group consisting of chromium, tin, vanadium and wolfram, in an amount of 1-3 mg of each of the chosen mineral elements, the amounts being calculated as daily intake.

### Claim 16 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent comprises strontium, serine and vanadium.

### Claim 17 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent comprises arginine and vanadium.

### Claim 18 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent comprises strontium and isoleucin and at least one mineral element selected from the group consisting of chromium, tin, vanadium, selenium, and wolfram

### Claim 19 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent is in the form of a food additive or a food ingredient.

### Claim 20 (depends on 12)

A method of treatment or prophylaxis of cancer according to claim 12, characterized in that the pharmaceutical agent is in the form of a dairy product.

### Claim 21 (depends on 20)

A method of treatment or prophylaxis of cancer according to claim 20 characterized in that the pharmaceutical agent is in the form of yoghurt.
